D'ANNA, Rosario
 Distribuzione geografica
Continente #
EU - Europa 9.186
NA - Nord America 7.011
AS - Asia 4.183
SA - Sud America 1.486
AF - Africa 129
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 2
Totale 22.011
Nazione #
US - Stati Uniti d'America 6.876
RU - Federazione Russa 4.663
SG - Singapore 1.759
CN - Cina 1.299
BR - Brasile 1.271
IE - Irlanda 1.029
SE - Svezia 1.027
IT - Italia 628
HK - Hong Kong 436
DE - Germania 425
UA - Ucraina 316
FR - Francia 300
VN - Vietnam 231
PL - Polonia 215
FI - Finlandia 206
GB - Regno Unito 190
IN - India 110
AR - Argentina 79
CA - Canada 60
BD - Bangladesh 49
MX - Messico 49
BE - Belgio 42
ZA - Sudafrica 39
JP - Giappone 37
TR - Turchia 35
EC - Ecuador 33
NL - Olanda 32
IQ - Iraq 30
UZ - Uzbekistan 25
MA - Marocco 23
AT - Austria 22
CO - Colombia 22
ID - Indonesia 21
PK - Pakistan 21
ES - Italia 19
VE - Venezuela 18
IR - Iran 17
CZ - Repubblica Ceca 15
UY - Uruguay 15
EG - Egitto 14
TN - Tunisia 14
PH - Filippine 13
PY - Paraguay 13
AL - Albania 12
PE - Perù 12
AE - Emirati Arabi Uniti 11
AU - Australia 11
CL - Cile 10
KE - Kenya 10
AZ - Azerbaigian 9
SA - Arabia Saudita 9
BO - Bolivia 8
JM - Giamaica 8
KZ - Kazakistan 8
RO - Romania 8
JO - Giordania 7
LT - Lituania 7
CI - Costa d'Avorio 6
DO - Repubblica Dominicana 6
KR - Corea 6
MY - Malesia 6
OM - Oman 6
GY - Guiana 5
KH - Cambogia 5
RS - Serbia 5
AM - Armenia 4
DZ - Algeria 4
LB - Libano 4
LU - Lussemburgo 4
MN - Mongolia 4
SN - Senegal 4
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
CH - Svizzera 3
ET - Etiopia 3
GR - Grecia 3
HN - Honduras 3
IL - Israele 3
NG - Nigeria 3
NP - Nepal 3
NZ - Nuova Zelanda 3
BN - Brunei Darussalam 2
BY - Bielorussia 2
GE - Georgia 2
LV - Lettonia 2
MD - Moldavia 2
NO - Norvegia 2
PA - Panama 2
PS - Palestinian Territory 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BW - Botswana 1
CG - Congo 1
CR - Costa Rica 1
CY - Cipro 1
EU - Europa 1
GA - Gabon 1
Totale 21.995
Città #
Moscow 1.305
Ashburn 1.221
Dublin 1.029
Singapore 1.024
Chandler 736
Dallas 679
Jacksonville 647
Nyköping 513
Beijing 475
Hong Kong 435
San Jose 230
Warsaw 201
Messina 187
The Dalles 187
Princeton 170
Boardman 162
Lauterbourg 160
Cambridge 157
Los Angeles 157
Medford 153
Dearborn 144
Ann Arbor 139
Des Moines 128
São Paulo 103
Munich 101
Buffalo 80
Ho Chi Minh City 78
New York 72
Jinan 58
Woodbridge 53
Hanoi 52
Frankfurt am Main 46
Wilmington 44
Redondo Beach 42
Guangzhou 41
Tianjin 41
Shenyang 40
Brussels 39
Belo Horizonte 37
Santa Clara 37
Catania 35
Turku 35
San Mateo 33
Rio de Janeiro 31
Bremen 30
Orem 30
Tokyo 30
Zhengzhou 30
Hyderabad 29
Lancaster 28
Düsseldorf 26
Hebei 26
London 26
Brooklyn 25
Curitiba 25
Houston 24
Porto Alegre 24
Shanghai 24
Brasília 23
Helsinki 23
Seattle 23
Chennai 22
Council Bluffs 22
Montreal 21
Ningbo 21
Rome 21
Tashkent 21
Johannesburg 20
Shenzhen 20
Denver 19
Nanjing 19
Stockholm 19
Boston 17
Haikou 17
Pune 17
Taizhou 17
Atlanta 15
Sorocaba 15
Baghdad 14
Dong Ket 14
Manchester 14
Ottawa 14
Washington 14
Milan 13
Campinas 12
Chicago 12
Fortaleza 12
Guarulhos 12
Guayaquil 12
Mexico City 12
Montevideo 12
Quito 12
San Francisco 12
Amsterdam 11
Campo Grande 11
Goiânia 11
Hefei 11
Jakarta 11
Lanzhou 11
Mumbai 11
Totale 12.374
Nome #
Inositolo e sindrome metabolica in menopausa 288
Myo-inositol Supplementation for Prevention of Gestational Diabetes in Obese Pregnant Women: A Randomized Controlled Trial 241
Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow-up study 230
Coffee intake during pregnancy and neonatal low birth weight: data from a multicenter Italian cross sectional study 230
Antiviral activity of Ellagic acid and Annona Muricata in cervical HPV related pre-neoplastic lesions: A randomized trial 225
Adiponectin and insulin resistance in early- and late-onset pre-eclampsia 223
Metabolic effects of breastfeeding in women with previous gestational diabetes diagnosed according to the IADPSG criteria 213
Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial 208
Italian risk factor-based screening for gestational diabetes. 207
ADAM 12 and PAPP-A at 14–17 weeks' gestation as biomarkers of pre-eclampsia. 206
Myo-inositol and melatonin in the menopausal transition 205
Bone remodeling and regulation of sRANKL/OPG balance after genistein administration in osteopenic, postmenopausal women 202
A single abnormal value of the glucose tolerance test is related to increased adverse perinatal outcome. 199
Perinatal outcome in a Caucasian population with gestational diabetes and preexisting diabetes first diagnosed in pregnancy 198
Abnormal glucose tolerance later in life in women affected by glucose intolerance during pregnancy 196
Clinical and metabolic outcomes in pregnant women at risk for gestational diabetes mellitus supplemented with myo-inositol: a secondary analysis from 3 RCTs 195
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. 190
A New Supplement for the Treatment of Metabolic Syndrome in Postmenopausal Women 187
Antiosteoporotic activity of genistein aglycone in postmenopausal women: Evidence from a post-hoc analysis of a multicenter randomized controlled trial 186
Effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome: a perspective, randomized, placebo-controlled study. 185
Myo-inositol may prevent gestational diabetes in PCOS women 185
Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study 181
Effects of myo-inositol on glucose variability in women with gestational diabetes 181
OPG and sRANKL serum concentrations in osteopenic, postmenopausal women after 2-year genistein administration. 178
Cardiac diastolic evaluation in pregnant women with abnormal glucose tolerance: an opportunity to detect the early and subclinical alterations and prevent cardiovascular diseases 178
Cardiovascular effects of raloxifene hydrochloride 177
C-reactive protein as an early predictor of gestational diabetes mellitus 175
Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: A two-year randomized, double-blind, placebo-controlled study 173
Vigilance on use of drugs, herbal products, and food supplements during pregnancy: focus on fosfomycin 173
Concentration of circulating endothelial progenitor cells (EPC) in normal pregnancy and in pregnant women with diabetes and hypertension 172
Decreased endothelial progenitor cells (EPCs) and increased Natural Killer (NK) cells in peripheral blood as possible early markers of preeclampsia: a case-control analysis 172
B cell leukaemia/lymphoma-2 protein concentrations during normal pregnancy 171
Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo controlled study. 169
GENISTEIN AGLYCONE DOES NOT AFFECT THYROID FUNCTION: RESULTS FROM A THREE-YEAR, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL 168
Neutrophil gelatinase-associated lipocalin serum evaluation through normal pregnancy and in pregnancies complicated by preeclampsia. 167
Peroxisome proliferator-activated receptor modulation during metabolic diseases and cancers: master and minions 167
Closed vs. Open Oocyte Vitrification Methods Are Equally Effective for Blastocyst Embryo Transfers: Prospective Study from a Sibling Oocyte Donation Program 167
Peripheral blood CD34+ cells as a novel and noninvasive early marker of first trimester miscarriage: results from a case-control analysis 166
Efficacy of genistein aglycone on some cardiovascular risk factors and homocysteine levels: A follow-up study 165
First trimester serum PAPP-A and NGAL in the prediction of late-onset pre-eclampsia. 165
Wnt antagonist sclerostin and Dickkopf-1 in gestational diabetes 165
First trimester serum neutrophil gelatinase-associated lipocalin in gestational diabetes 163
ADAM 12 come marker precoce di preeclampsia 161
Association of maternal food insecurity before and during pregnancy with fetal structural anomalies: A multicenter case-control study protocol 161
Plasma homocysteine in early and late pregnancies complicated with preeclampsia and isolated intrauterine growth restriction 160
Compliance with hormone replacement therapy in postmenopausal Sicilian women 160
Cardiovascular effects of the phytoestrogen genistein 160
One-year effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome 160
Dietary management of skin health: The role of genistein 160
Positive association between a single abnormal glucose tolerance test value in pregnancy and subsequent abnormal glucose tolerance 157
Improvement of selective screening strategy for gestational diabetes through a more accuratedefinition of high-risk groups 157
EFFECTS OF THE PHYTOESTROGEN GENISTEIN ON CARDIOVASCULAR RISK FACTORS IN POSTMENOPAUSAL WOMEN. 157
Differenze socio.demografiche e psicologiche tra gruppi di pazienti in peri e post menopausa 156
Maternal serum PAPP-A as an early marker of obstetric complications? 154
Myo-inositol supplementation to prevent gestational diabetes in overweight non-obese women: bioelectrical impedance analysis, metabolic aspects, obstetric and neonatal outcomes–a randomized and open-label, placebo-controlled clinical trial 153
Myo-inositol supplementation and the onset of gestational diabetes mellitus in pregnant women with a family hystory of type 2 diabetes. A prospective, randomized, placebo controlled study 152
Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: A randomized double-blind placebo-controlled study 152
ICAM-1 in maternal serum and amniotic fluid as an early marker of preeclampsia and IUGR 151
Effects of phytoestrogen genistein on cytogenetic biomarkers in postmenopausal women: 1 year randomized, placebo-controlled study 150
Is mid-trimester maternal serum inhibin-A a marker of preeclampsia or intrauterine growth restriction? 149
Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women - A randomized trial 149
Effects of genistein on hot flushes in early postmenopausal women: a randomized, double-blind EPT- and Placebo-controlled Study 148
Effects of the phytoestrogen genistein on the circulating soluble receptor activator of nuclear factor kappa B ligand-osteoprotegerin system in early postmenopausal women 148
Midtrimester amniotic fluid adiponectin in normal pregnancy. 147
Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia. 147
Randomized double-blind study evaluating the efficacy on uterine fibroids shrinkage and on intra-operative blood loss of different length of leuprolide acetate depot treatment before myomectomy 146
Plasma adiponectin concentration in early pregnancy and subsequent risk of hypertensive disorders 146
CORRESPONDENCE BETWEEN FIRST TRIMESTER FASTING GLICEMIA AND ORAL GLUCOSE TOLERANCE TEST IN GESTATIONAL DIABETES DIAGNOSIS 145
Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo-controlled study 142
Effetti del fitoestrogeno genisteina su donne in post-menopausa affette da sindrome metabolica 142
Genistein effects on quantitative ultrasound parameters and bone mineral density in osteopenic postmenopausal women 142
Effects of a new vaginal cream containing visnadine, prenylflavonoids and bovine colostrum on Vaginal Health Index Score and Female Sexual Function Index in post-menopausal sexually active women affected by vaginal dryness: A pilot study 141
SCLEROSTIN AND DICKKOPF-1 IN PREGNANT WOMEN WITH GESTATIONAL DIABETES 137
SICUREZZA ED EFFICACIA DELLA GENISTEINA IN DONNE OSTEOPENICHE IN POSTMENOPAUSA 136
Midtrimester Amniotic Fluid Leptin and Insulin Levels and Subsequent Gestational Diabetes. 136
Effects of prepregnancy body mass index and weight gain during pregnancy on perinatal outcome in glucose-tolerant women. 136
Pregnancy outcome following mid-trimester amniocentesis 136
Anti-SARS-CoV2 IgG are present in the amniotic fluid of both infected and vaccinated women at second trimester of pregnancy: a cohort study 135
La disfunzione diastolica nel diabete gestazionale 134
The phytoestrogen alpha-zearalenol reverses endothelial dysfunction induced by oophorectomy in rats 132
First- and Second-Trimester ADAM12s in Down Syndrome Screening. 132
Second trimester neutrophil gelatinase-associated lipocalin as a potential prediagnostic marker of preeclampsia. 132
Effects of a New Flavonoid and Myo-Inositol Supplement on Some Biomarkers of Cardiovascular Risk in Postmenopausal Women: A Randomized Trial 131
Myoinositol plus α‑lactalbumin supplementation, insulin resistance and birth outcomes in women with gestational diabetes mellitus: a randomized, controlled study 131
Effect of genistein on endothelial function in postmenopausal women: A randomized, double-blind, controlled study 127
Prevalence of risk factors in the screening of carbohydrate intolerance in pregnancy 126
Effects of genistein aglycone on endometrial hyperplasia in premenopausal women: a randomized controlled trial 126
Myo-inositol in Down syndrome amniotic fluid. A case-control study. 126
Prevalenza dei fattori di rischio associati al diabete gestazionale e alla ridotta tolleranza glucidica in gravidanza 125
Myo-Inositol for the Prevention of Gestational Diabetes Mellitus. A Brief Review 124
The ESR2 AluI 1730G>A (rs4986938) gene polymorphism is associated with fibrinogen plasma levels in postmenopausal women 116
A developmental approach to the prevention of hypertension and kidney disease: a report from the Low Birth Weight and Nephron Number Working Group 116
Interleukin 31 is involved in intrahepatic cholestasis of pregnancy 116
Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma NO concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women 115
Livelli serici di OPG e RANKL in donne osteopeniche in post-menopausa, trattate per 2 anni col fitoestrogeno genisteina 114
Use of diet and myoinositol in postmenopausal women: a new approach to the metabolic syndrome 114
The clinical utility of serum uric acid measurements in pre- eclampsia and transient hypertension in pregnancy 112
Valutazione ecocardiografica in pazienti affette da diabete mellito gestazionale: Dati preliminari 112
GENISTEIN AGLYCONE: A DUAL MODE OF ACTION ANTI-OSTEOPOROTIC SOY ISOFLAVONE REBALANCING BONE TURNOVER TOWARDS BONE FORMATION 111
The impact of kidney development on the life course: a consensus document for action 110
Totale 16.043
Categoria #
all - tutte 70.319
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.319


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021271 0 0 0 0 0 0 0 0 0 138 79 54
2021/20221.216 11 145 29 44 47 15 70 44 35 282 148 346
2022/20233.036 223 283 149 185 252 300 33 177 1.289 16 96 33
2023/2024770 60 108 43 106 62 111 27 30 0 58 21 144
2024/20253.387 68 29 70 221 147 132 54 717 850 238 325 536
2025/202610.293 595 724 733 759 811 2.217 1.282 1.359 1.458 355 0 0
Totale 22.280